2-Chlorobenzoate biodegradation by recombinant Burkholderia cepacia under hypoxic conditions in a membrane bioreactor

The feasibility of applying bacterial hemoglobin technology to degrade 2-chlorobenzoate (2-CBA) through co-metabolism under hypoxic conditions in a membrane bioreactor (MBR) process has been studied in the laboratory. 2-chlorobenzoate removal and chloride release rates in the MBR system varied from...

Description complète

Détails bibliographiques
Publié dans:Water environment research : a research publication of the Water Environment Federation. - 1998. - 77(2005), 5 vom: 03. Sept., Seite 511-8
Auteur principal: Urgun-Demirtas, Meltem (Auteur)
Autres auteurs: Stark, Benjamin, Pagilla, Krishna
Format: Article
Langue:English
Publié: 2005
Accès à la collection:Water environment research : a research publication of the Water Environment Federation
Sujets:Journal Article Research Support, U.S. Gov't, Non-P.H.S. Chlorides Chlorobenzoates Medical Waste Disposal 2-chlorobenzoic acid 8P0867193V Oxygen S88TT14065
Description
Résumé:The feasibility of applying bacterial hemoglobin technology to degrade 2-chlorobenzoate (2-CBA) through co-metabolism under hypoxic conditions in a membrane bioreactor (MBR) process has been studied in the laboratory. 2-chlorobenzoate removal and chloride release rates in the MBR system varied from 99 to 78% and 98 to 73%, respectively, depending on the operation conditions. Chemical oxygen demand (COD) removal efficiencies were more than 90% at food-to-microorganism ratios ranging from 0.32 to 0.62 g/g/d, and the observed yield was 0.13 to 0.20 g biomass/g COD. The bacterial cell-floc size-distribution analysis showed that there is a significant change in bacterial floc size due to high shear stress during operation of the MBR. To characterize growth kinetics of Burkholderia cepacia strain dinitrotoluene, a mathematical model that describes co-metabolic oxidation of 2-CBA in an MBR has been developed
Description:Date Completed 20.01.2006
Date Revised 22.09.2019
published: Print
Citation Status MEDLINE
ISSN:1554-7531